Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cineverse Corp.CIDM · Entity 7143 | 10% owner | July 09, 2019 | November 21, 2019 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC.BCACU · Entity 157082 | 10% owner | June 28, 2017 | June 28, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cineverse Corp.
Report date July 09, 2019 · Filed November 21, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy holding | 23,566,667 |
Last balance in matching sequence
After 2019-08-02 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2019-07-09 · Purchase · Acquired 2,000,000 · Balance 21,666,667 F3: Representing 2,000, 000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated July 9, 2019 and transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019. F1: Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group ("BEMG") who then holds 100% equity interest of Bison Entertainment Investment Limited ("BEI").,. Row 2 · 2019-08-02 · Purchase · Acquired 1,900,000 · Balance 23,566,667 F4: Representing 1,900,000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated August 2, 2019 and later transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019. F1: Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group ("BEMG") who then holds 100% equity interest of Bison Entertainment Investment Limited ("BEI").,. |
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.80 · Expires 2022-12-29 | IndirectSee Footnotes | 1,400,000 |
Reported balance
Holding disclosure · report date 2019-07-09 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 1,400,000 F1: Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group ("BEMG") who then holds 100% equity interest of Bison Entertainment Investment Limited ("BEI").,. F2: Warrants held by BEMG. The warrants to purchase up to 1,400,000 shares of Class A Common Stock of the Company were issued by Cinedigm Corp. (the "Company") to BEMG on December 29, 2017 in connection with its agreement to make a loan to the Company in the principal amount of US$10,000,000. |
Filing footnotes · ownership attribution and instrument terms
F1: Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group ("BEMG") who then holds 100% equity interest of Bison Entertainment Investment Limited ("BEI").,.
F2: Warrants held by BEMG. The warrants to purchase up to 1,400,000 shares of Class A Common Stock of the Company were issued by Cinedigm Corp. (the "Company") to BEMG on December 29, 2017 in connection with its agreement to make a loan to the Company in the principal amount of US$10,000,000.
F3: Representing 2,000, 000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated July 9, 2019 and transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019.
F4: Representing 1,900,000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated August 2, 2019 and later transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019.
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
Report date June 28, 2017 · Filed June 28, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary share, no par valueSEC Table I · non-derivative | Indirect(3) See Footnote | 1,519,600 |
Reported balance
After 2017-06-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2017-06-28 · Purchase · Acquired 39,375 · Balance 1,519,600 F1: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F3: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital. |
| RightsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Indirect(3) See Footnote | 401,875 |
Reported balance
After 2017-06-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-06-28 · Purchase · Acquired 39,375 · Balance 401,875 F1: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F2: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F3: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Indirect(3) See Footnote | 200,938 |
Reported balance
After 2017-06-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-06-28 · Purchase · Acquired 19,688 · Balance 200,938 F1: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F2: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F3: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement").
F2: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination.
F3: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2019 Filed Nov 21, 2019 22:49 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 1,900,000 | $2,850,000.00 | $5,415,000,000,000.00 |
DisclosureSEC source: 0001213900-19-024380 · ownership.xml · nonDerivative · entry 2 Jiang Fengyun · CIK 0001705836 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By holding Disclosed balance after: 23,566,667 F4 · shares: Representing 1,900,000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated August 2, 2019 and later transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019. F1 · ownership.nature: Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group ("BEMG") who then holds 100% equity interest of Bison Entertainment Investment Limited ("BEI").,. Read SEC document |
| July 09, 2019 Filed Nov 21, 2019 22:49 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 2,000,000 | $4,500,000.00 | $9,000,000,000,000.00 |
DisclosureSEC source: 0001213900-19-024380 · ownership.xml · nonDerivative · entry 1 Jiang Fengyun · CIK 0001705836 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By holding Disclosed balance after: 21,666,667 F3 · shares: Representing 2,000, 000 shares of Class A Common Stock originally issued to BEMG at $1.50 per share pursuant to a purchase agreement between the Company and BEMG dated July 9, 2019 and transferred by BEMG to BEI pursuant to a share transfer agreement among BEMG and BEI dated October 24, 2019. F1 · ownership.nature: Bison Capital Holding Company Limited owns 100% equity interest of Bison Entertainment and Media Group ("BEMG") who then holds 100% equity interest of Bison Entertainment Investment Limited ("BEI").,. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 17:29 UTC | Cineverse Corp. CIDM · Entity 7143 | OtherWarrants (right to buy) · Derivative | 1,400,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000899243-18-000035 · doc4.xml · derivative · entry 2 Bison Entertainment & Media Group · CIK 0001722103 · 10% owner Bison Capital Holding Co Ltd · CIK 0001593415 · 10% owner Jiang Fengyun · CIK 0001705836 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400,000 Underlying: Class A Common Stock · 1,400,000 shares Expires 2022-12-29 F2 · kind: Warrants held by BEMG. The warrants to purchase up to 1,400,000 shares of Class A Common Stock of the Company were issued by the Company to BEMG on December 29, 2017 in connection with its agreement to make a loan to the Company in the principal amount of US$10,000,000.00. F2 · price: Warrants held by BEMG. The warrants to purchase up to 1,400,000 shares of Class A Common Stock of the Company were issued by the Company to BEMG on December 29, 2017 in connection with its agreement to make a loan to the Company in the principal amount of US$10,000,000.00. Read SEC document |
| June 28, 2017 Filed Jun 28, 2017 17:10 UTC | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. BCACU · Entity 157082 | PurchaseWarrants · Derivative | 19,688 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001213900-17-006912 · f4062817jiang_bisoncapital.xml · derivative · entry 3 Jiang Fengyun · CIK 0001705836 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · (3) See Footnote Disclosed balance after: 200,938 Underlying: Ordinary share · 19,688 shares Expires not disclosed F1 · kind: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F1 · price: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F2 · derivative.exercise_date: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F2 · derivative.expiration_date: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F2 · derivative.underlying_shares: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F3 · ownership.direct: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital. Read SEC document |
| June 28, 2017 Filed Jun 28, 2017 17:10 UTC | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. BCACU · Entity 157082 | PurchaseRights · Derivative | 39,375 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001213900-17-006912 · f4062817jiang_bisoncapital.xml · derivative · entry 2 Jiang Fengyun · CIK 0001705836 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · (3) See Footnote Disclosed balance after: 401,875 Underlying: Ordinary share · 3,937 shares Expires not disclosed F1 · kind: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F1 · price: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F2 · derivative.exercise_date: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F2 · derivative.expiration_date: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F2 · derivative.underlying_shares: Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. F3 · ownership.direct: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital. Read SEC document |
| June 28, 2017 Filed Jun 28, 2017 17:10 UTC | XYNOMIC PHARMACEUTICALS HOLDINGS, INC. BCACU · Entity 157082 | PurchaseOrdinary share, no par value | 39,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-006912 · f4062817jiang_bisoncapital.xml · nonDerivative · entry 1 Jiang Fengyun · CIK 0001705836 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · (3) See Footnote Disclosed balance after: 1,519,600 F1 · kind: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F1 · shares: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F1 · price: In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement"). F3 · ownership.direct: Mrs. Fengyun Jiang, holds 80% ownership of Bison Capital and her spouse, Mr. Peixin Xu holds 20% ownership of Bison Capital. With Mr. Xu, Mrs. Jiang jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.